Jenscare Scientific Future Growth
Future criteria checks 2/6
Jenscare Scientific is forecast to grow revenue at 48.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 34.0% |
Revenue growth rate | 48.6% |
Future return on equity | -9.2% |
Analyst coverage | Low |
Last updated | 01 Mar 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,738 | N/A | 148 | N/A | 1 |
12/31/2025 | 553 | N/A | -27 | N/A | 3 |
12/31/2024 | 214 | -205 | -431 | N/A | 3 |
12/31/2023 | N/A | -372 | N/A | N/A | N/A |
9/30/2023 | N/A | -457 | N/A | N/A | N/A |
6/30/2023 | N/A | -542 | -246 | -191 | N/A |
3/31/2023 | N/A | -491 | -214 | -175 | N/A |
12/31/2022 | N/A | -439 | -182 | -158 | N/A |
9/30/2022 | N/A | -322 | -188 | -153 | N/A |
6/30/2022 | N/A | -205 | -168 | -148 | N/A |
3/31/2022 | N/A | -353 | -163 | -145 | N/A |
12/31/2021 | N/A | -501 | -157 | -142 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 9877's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 9877's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 9877's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 9877's revenue (48.6% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).
High Growth Revenue: 9877's revenue (48.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9877 is forecast to be unprofitable in 3 years.